The University of Chicago Header Logo

Connection

Mitchell Posner to Uracil

Back to Details
This is a "connection" page, showing publications Mitchell Posner has written about Uracil.
Mitchell Posner
Connection Strength
0.009
Uracil
  1. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study. Ann Oncol. 1998 Sep; 9(9):1035-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.